Prescription Treatment Access Survey

In fall 2025, NEA conducted a survey to learn about patient and caregiver experiences obtaining prescription treatments for atopic dermatitis. This survey was a follow up to our 2021 survey, and the information provided will help guide NEA’s advocacy program to establish and advance policy agendas that address patients’ unmet needs and improve patients’ ability to get quality care and treatment.

This survey closed in October 2025. The NEA research team is currently analyzing the data. Results and journal publications are forthcoming.